ROTEM Technology

ROTEM® is a seminal and quantum advanced technology over traditional methods for managing excessive bleeding. Targeted and evidence based, ROTEM® identifies the cause of bleeding, significantly reducing the usage of blood, its products and components, and avoids inappropriate transfusion. Within five-to-ten minutes,  the ROTEM® diagnostic device can determine the causes of bleeding including:

• Hyperfibrinolysis
• Platelet deficiency
• Fibrinogen deficiency
• Factor deficiency
• Heparin induced bleeding

Allowing for enhanced decision-making process in blood transfusion, ROTEM® minimizes the risks arising from RBC transfusion, including increased mortality, morbidity and hospital-acquired infection. It offers a panel approach for detecting, managing, monitoring hemostasis and preserving blood, while avoiding dangerous complications of blood transfusion. It provides reliable critical information about the efficacy of the therapy, monitoring and course-modification as needed.

Benefits of Patient Blood Management (PBM) and ROTEM® include the reduction of:

• Mortality by up to 68%
• Morbidity by up to 41%
• Infection rate by up to 81%
• RBC transfusion by 10-95%
• Hospital re-admission rate by up to 43%
• Reoperation rate by up to 43%
• Hospital length of stay by 16-33%
• Total hospital costs by 10-24%